Nationwide genomic analysis to study possible reasons for the low COVID-19 mortality rate in Japan

TOKYO, Sept. 29, 2020 /PRNewswire/ — Japanese researchers have launched the Joint Research Coronavirus Task Force to gather genetic information for predicting severe cases of COVID-19 and developing effective vaccines. 

National Network of Medical Institutions © Keio UniversityNational Network of Medical Institutions © Keio University
National Network of Medical Institutions © Keio University

The Keio Research Highlights website offers more details about this and other recent research being conducted by researchers at Keio University.

https://research-highlights.keio.ac.jp/

On 21 May, 2020, the Joint Research Coronavirus Task Force was launched in Japan to promote the development of a mucosal vaccine for COVID-19 based on advanced genomic analysis.

“We will analyze 600 blood samples taken from Japanese COVID-19 patients located in approximately 100 hospitals throughout Japan,” explains Takanori Kanai of the Keio University School of Medicine, who leads the task force. “One of the goals of the research is to try to understand why the mortality rate due to COVID-19 has remained significantly lower in

Read More